The immune system is built to communicate what’s going on. Our mission is to listen.
MeMed decodes the host-immune response to generate Insights that address tough clinical dilemmas and improve lives. We are excited to announce recent news that our host-immune response technology for COVID-19 risk stratification, MeMed COVID-19 Severity, has received CE Mark.
MeMed COVID-19 Severity measures multiple proteins from a single serum sample and applies machine learning to stratify the risk of COVID-19 patients to experience severe outcomes.